RAMB - AGOSTO 2017

59 / 70

Nunes RLV et al.
716 Rev Assoc Med Bras 2017; 63(8):711-716
12. Tang Y, Li J, Pu C, Bai Y, Yuan H, Wei Q, et al. Bipolar transurethral resection
versus monopolar transurethral resection for benign prostatic hypertrophy:
a systematic review and meta-analysis. J Endourol. 2014; 28(9):1107-14.
13. Gravas S, Bach T, Drake M, Gacci M, Gratzke C, Herrmann TRW, et al.
Treatment of non-neurogenic male LUTS: EAU Guideline. 2017. Available
from:
14. Malek RS, Kang HW, Coad JE, Koullick E. Greenlight photoselective 120-
watt 532-nm lithium triborate laser vaporization prostatectomy in living
canines. J Endourol. 2009; 23(5):837-45.
15. Hueber PA, Liberman D, Ben-Zvi T, Woo H, Hai MA, Te AE, et al. 180 W vs
120 W lithium triborate photoselective vaporization of the prostate for
benign prostatic hyperplasia: a global, multicenter comparative analysis of
perioperative treatment parameters. Urology. 2013; 82(5):1108-13.
16. Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A
multicenter randomized noninferiority trial comparing GreenLight-XPS
laser vaporization of the prostate and transurethral resection of the prostate
for the treatment of benign prostatic obstruction: two-yr outcomes of the
GOLIATH Study. Eur Urol. 2016; 69(1):94-102.
17. Stone BV, Chughtai B, Forde JC, Tam AW, Lewicki P, Te AE. Safety and
efficacy of GreenLight XPS laser vapoenucleation in prostates measuring
over 150mL. J Endourol. 2016; 30(8):906-12.
18. Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A
systematic review andmeta-analysis of functional outcomes and complications
following transurethral procedures for lower urinary tract symptoms resulting
from benign prostatic obstruction: an update. Eur Urol. 2015; 67(6):1066-96.
19. Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer
MR. Long-term results of a randomized trial comparing holmium laser
enucleation of the prostate and transurethral resection of the prostate:
results at 7 years. BJU Int. 2012; 109(3):408-11.
20. Brunckhorst O, Ahmed K, Nehikhare O, Marra G, Challacombe B, Popert
R. Evaluation of the learning curve for holmium laser enucleation of the
prostate using multiple outcome measures. Urology. 2015; 86(4):824-9.
21. Elshal AM, Elkoushy MA, El-Nahas AR, Shoma AM, Nabeeh A, Carrier S, et al.
GreenLight™ laser (XPS) photoselective vapo-enucleation versus holmium laser
enucleation of the prostate for the treatment of symptomatic benign prostatic
hyperplasia: a randomized controlled study. J Urol. 2015; 193(3):927-34.
22. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate
versus open prostatectomy for prostates greater than 100 grams: 5-year follow-
up results of a randomised clinical trial. Eur Urol. 2008; 53(1):160-6.
23. Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C. Long-term
results of open transvesical prostatectomy from a contemporary series of
patients. Urology. 2004; 64(2):306-10.
24. Li M, Qiu G, Hou Q, Wang D, Huang W, Hu C, et al. Endoscopic enucleation
versus open prostatectomy for treating large benign prostatic hyperplasia: a
meta-analysis of randomized controlled trials. PLoS One. 2015; 10(3):e0121265.
25. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al.
Holmium laser enucleation of the prostate versus open prostatectomy for
prostate > 70 g: 24-months follow up. Eur Urol. 2006; 50(3):563-8.
26. Tubaro A, Carter S, Hind A, Vicentini C, Miano L. A prospective study of
the safety and efficacy of suprapubic transvesical prostatectomy in patients
with benign prostatic hyperplasia. J Urol. 2001; 166(1):172-6.
27. Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D, et
al.; Members of the Sicilian-Calabrian Society of Urology. Open prostatectomy
for benign prostatic enlargement in southern Europe in the late 1990s: a
contemporary series of 1800 interventions. Urology. 2002; 60(4):623-7.
28. Elshal AM, El-Nahas AR, Barakat TS, Elsaadany MM, El-Hefnawy AS.
Transvesical open prostatectomy for benign prostatic hyperplasia in the era
of minimally invasive surgery: perioperative outcomes of a contemporary
series. Arab J Urol. 2013; 11(4):362-8.
29. Dall’Oglio MF, Srougi M, Antunes AA, Crippa A, Cury J. An improved
technique for controlling bleeding during simple retropubic prostatectomy:
a randomized controlled study. BJU Int. 2006; 98(2):384-7.
30. Schuessler WW, Kavoussi LR, Clayman RV, Vancaille TH. Laparoscopic
radical prostatectomy: initial case report. J Urol. 1992; 147:246A.
31. MarianoMB, Graziottin TM, Tefilli MV. Laparoscopic prostatectomy for vascular
control for benign prostatic hyperplasia. J Urol. 2002; 167(6):2528-9.
32. Sotelo R, Clavijo R, Carmona O, Garcia A, Banda E, Miranda M, et al. Robotic
simple prostatectomy. J Urol. 2008; 179(2):513-5.
33. Baumert H, Ballaro A, Dugardin F, Kaisary AV. Laparoscopic versus open
simple prostatectomy: a comparative study. J Urol. 2006; 175(5):1691-4.
34. Porpiglia F, Terrone C, Renard J, Grande S, Musso F, Cossu M, et al.
Transcapsular adenomectomy (Milin): a comparative study, extraperitoneal
laparoscopic versus open surgery. Eur Urol. 2006; 49(1):120-6.
35. McCullough TC, Heldwein FL, Soon SJ, Galiano M, Barret E, Cathelineau
X, et al. Laparoscopic versus open simple prostatectomy: an evaluation of
morbidity. J Endourol. 2009; 23(1):129-33.
36. Lucca I, Shariat SF, Hofbauer SL, Klatte T. Outcomes of minimally invasive
simple prostatectomy for benign prostatic hyperplasia: a systematic review
and meta-analysis. World J Urol. 2015; 33(4):563-70.
37. Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL,
et al. Perioperative outcomes of robotic and laparoscopic simple
prostatectomy: a European-American multi-institutional analysis. Eur Urol.
2015; 68(1):86-94.
38. Mitchell ME, Waltman AC, Athanasoulis CA, Kerr WS Jr, Dretler SP. Control
of massive prostatic bleeding with angiographic techniques. J Urol. 1976;
115(6):692-5.
39. Barbieri A, Simonazzi M, Marcato C, Larini P, Barbagallo M, Frattini A, et
al. Massive hematuria after transurethral resection of the prostate:
management by intra-arterial embolization. Urol Int. 2002; 69(4):318-20.
40. Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D. Arterial
embolization for massive hematuria following transurethral prostatectomy.
J Urol. 2002; 168(6):2550-1.
41. DeMeritt JS, Elmasri FF, EspositoMP, Rosenberg GS. Relief of benign prostatic
hyperplasia-related bladder outlet obstruction after transarterial polyvinyl
alcohol prostate embolization. J Vasc Interv Radiol. 2000; 11(6):767-70.
42. Sun F, Sánchez FM, Crisóstomo V, Lima JR, Luis L, García-Martínez V, et al.
Benign prostatic hyperplasia: transcatheter arterial embolization as potential
treatment: preliminary study in pigs. Radiology. 2008; 246(3):783-9.
43. Carnevale FC, Antunes AA, Motta Leal Filho JM, Oliveira Cerri LM, Baroni
RH, Marcelino AS, et al. Prostatic artery embolization as a primary treatment
for benign prostatic hyperplasia: preliminary results in two patients.
Cardiovasc Intervent Radiol. 2010; 33(2):355-61.
44. Antunes AA, Carnevale FC, da Motta Leal Filho JM, Yoshinaga EM, Cerri
LM, Baroni RH, et al. Clinical, laboratorial, and urodynamic findings of
prostatic artery embolization for the treatment of urinary retention related
to benign prostatic hyperplasia. A prospective single-center pilot study.
Cardiovasc Intervent Radiol. 2013; 36(4):978-86.
45. Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M, et al. Benign prostatic
hyperplasia: prostatic arterial embolization versus transurethral resection
of the prostate: a prospective, randomized, and controlled clinical trial.
Radiology. 2014; 270(3):920-8.
46. Pyo JS, Cho WJ. Systematic review and meta-analysis of prostatic artery
embolisation for lower urinary tract symptoms related to benign prostatic
hyperplasia. Clin Radiol. 2017; 72(1):16-22.
47. Pisco JM, Rio-Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes
L, et al. Embolisation of prostatic arteries as treatment of moderate to severe
lower urinary symptoms (LUTS) secondary to benign hyperplasia: results
of short- and mid-term follow-up. Eur Radiol. 2013; 23(9):2561-72.
48. Faber K, Abreu AL, Ramos P, Aljuri N, Mantri S, Gill I, et al. Image-guided robot-
assisted prostate ablation using water jet-hydrodissection: initial study of a novel
technology for benign prostatic hyperplasia. J Endourol. 2015; 29(1):63-9.
49. Pimentel MA, Nair SM, Gilling PJ. Aquablation™: early clinical results. Curr
Bladder Dysfunct Rep. 2016; 11(2):130-3.
50. Gilling P, Reuther R, Kahokehr A, Fraundorfer M. Aquablation – image-
guided robot-assisted waterjet ablation of the prostate: initial clinical
experience. BJU Int. 2016; 117(6):923-9.
51. Gilling P, Anderson P, Tan A. Aquablation of the prostate for symptomatic
benign prostatic hyperplasia: 1-year results. J Urol. 2017; 197(6):1565-72.
52. Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective
water vapor as a treatment for lower urinary tract symptomatology due to
benign prostatic hyperplasia using the Rezüm(®) system: evaluation of acute
ablative capabilities in the human prostate. Res Rep Urol. 2015; 7:13-8.
53. McVary KT, Gange SN, GittelmanMC, Goldberg KA, Patel K, Shore ND, et al.
Minimally invasive prostate convective water vapor energy ablation: amulticenter,
randomized, controlled study for the treatment of lower urinary tract symptoms
secondary to benign prostatic hyperplasia. J Urol. 2016; 195(5):1529-38.
54. Ray A, Morgan H, Wilkes A, Carter K, Carolan-Rees G. The Urolift System
for the treatment of lower urinary tract symptoms secondary to benign
prostatic hyperplasia: a NICE medical technology guidance. Appl Health
Econ Health Policy. 2016; 14(5):515-26.